Injectable codeine is obtainable for subcutaneous or intramuscular injection only; intravenous injection is contraindicated, as this may lead to nonimmune mast-cell degranulation and ensuing anaphylactoid reaction. Codeine suppositories also are marketed in a few countries. In Ireland, new rules came into impact on 1 August 2010[90] relating to codeine, as https://codeingil.com/